Article Excerpt: November is fast approaching, and with it comes the Drug Enforcement Administration’s (DEA) proposed rule on telehealth and controlled substance prescribing. After a six-month delay, the federal law enforcement and regulatory body will release regulations that will shape the future of telehealth within behavioral health in the post-COVID era. It also has the potential to redirect the evolution of telehealth in the behavioral health industry. Companies that exclusively or heavily focus on providing care via telehealth have had to prepare for the potential snapback to a regulatory environment where in-person exams were required before a telehealth provider could prescribe certain controlled substances.
Full Article: https://tinyurl.com/abd4vzmn
Article Source: Behavioral Health Business